$Histogenics(OCGN)$I turned bearish after seeing the numbers and earning calls. Fundamentally the company is weak. But good for trade or swing. Please be mindful US is having surplus vaccine. For Covaxin to be sold in US they'll need EUA approval ASAP.
$Histogenics(OCGN)$ good dip to buy. Covaxin effective against 3 new mutated variant including india's double mutant. EUA and FDA on the way, once approved we will be positioned near Moderna's market cap if not Novavax. Easy storage, charging 10bucks per vax, 40% net profit deal partnership w India. Imagine the possibilities. This Friday is the day